Latest / Community Health Media
Dr. VK Gadi & Dr. Anne O'Dea - Advances in HER2 Positive Breast Cancer Treatment
Watch this enlightening conversation focused on the transforming power of antibody-drug conjugates (ADCs) like T-DXd (trastuzumab deruxtecan) in HER2-positive breast cancer therapy with Dr. Anne O’Dea and Dr. VK Gadi. The doctors provide hope for T-DXd’s potential usage as a first-line treatment, which could change present guidelines away from conventional chemotherapy treatments like the Cleopatra regimen, notable for their high toxicity. Effective, focused therapy with less side effects provided by T-DXd could improve patients’ quality of life and maybe increase general survival.They also…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.